Mimedx Group Appoints New Officers and Directors
Ticker: MDXG · Form: 8-K · Filed: Mar 4, 2024 · CIK: 1376339
| Field | Detail |
|---|---|
| Company | Mimedx Group, Inc. (MDXG) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-changes, personnel
Related Tickers: MDXG
TL;DR
MDXG shakes up leadership with new CMO, CSO, and board members.
AI Summary
Mimedx Group, Inc. announced on February 29, 2024, changes in its executive team and board. Specifically, the company appointed Dr. Christopher J. Weber as Chief Medical Officer and Dr. Michael J. DeGeorge as Chief Scientific Officer. Additionally, the company elected two new directors, Ms. Karen L. King and Mr. William D. Inc. to its Board of Directors.
Why It Matters
These executive and board changes could signal a strategic shift or a renewed focus on innovation and leadership within Mimedx Group.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and performance.
Key Players & Entities
- Mimedx Group, Inc. (company) — Registrant
- Dr. Christopher J. Weber (person) — Appointed Chief Medical Officer
- Dr. Michael J. DeGeorge (person) — Appointed Chief Scientific Officer
- Ms. Karen L. King (person) — Elected to Board of Directors
- Mr. William D. Inc. (person) — Elected to Board of Directors
- February 29, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Christopher J. Weber has been appointed as the new Chief Medical Officer.
Who is the new Chief Scientific Officer?
Dr. Michael J. DeGeorge has been appointed as the new Chief Scientific Officer.
Who are the newly elected directors?
Ms. Karen L. King and Mr. William D. Inc. have been elected to the Board of Directors.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is February 29, 2024.
What is the company's principal executive office address?
The principal executive offices are located at 1775 West Oak Commons Ct., NE, Marietta GA 30062.
Filing Stats: 463 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2024-03-04 08:11:28
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share MDXG The Nasdaq Sto
Filing Documents
- mdxg-20240229.htm (8-K) — 25KB
- ex991-newdirectorspressrel.htm (EX-99) — 6KB
- image_0a.jpg (GRAPHIC) — 17KB
- 0001376339-24-000011.txt ( ) — 181KB
- mdxg-20240229.xsd (EX-101.SCH) — 2KB
- mdxg-20240229_lab.xml (EX-101.LAB) — 25KB
- mdxg-20240229_pre.xml (EX-101.PRE) — 13KB
- mdxg-20240229_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d)Exhibits. Exhibit No. Description of Exhibit 99.1 Press Release dated March 4, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIMEDX GROUP, INC. March 4, 2024 By: /s/William F. Hulse IV William F. Hulse IV General Counsel and Chief Administrative Officer